Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

ONTY $2.90 0.3900 +15.54%
CBMG $35.60 4.4700 +14.36%
XBIT $20.50 1.4501 +7.61%
VBLT $5.39 0.3400 +6.73%
VSTM $8.84 0.4200 +4.99%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CVM $0.73 -0.0610 -7.71%
CALA $11.11 -0.9100 -7.57%
PVCT $0.77 -0.0556 -6.72%
BDSI $8.01 -0.4801 -5.65%
CLSN $2.67 -0.1300 -4.64%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

Childhood Cancer and Tx Have Lasting Sexual Effects

(MedPage Today) May 11, 2015 - Childhood cancers and their treatment often have long-lasting effects on patient's sexuality and sexual function, results of a small survey suggested.
read article (free registration required) 

Potential New Marker for Bacteremia in Child Cancers

(MedPage Today) May 13, 2015 - Highlights from the American Society of Pediatric Hematology/Oncology meeting.
read article (free registration required) 

Survival Rates for Rare Bone Cancer Still Low

(UPI) May 12, 2015 - A rare type of bone cancer continues to claim the lives of the majority of people who are diagnosed with the disease. A new study of the rare disorder found that survival remains low.
read article 

Simple Things Improve Head and Neck Cancer Survival

(Medscape Medical News) May 12, 2015 - There are some simple measures and circumstances that can improve overall survival in head and neck cancer, according to a single-center study published online May 27 in JAMA Otolaryngology.
read article (free registration required) 

Androgen Deprivation Therapy May Lead to Cognitive Impairment in Prostate Cancer Patients, Say Moffitt Cancer Center Researchers

(Moffitt) May 12, 2015 - A new Moffitt Cancer Center study indicated that men who are on androgen deprivation therapy have greater odds of experiencing impaired cognitive function.
read press release 

Three Times More Americans Are Spending $100,000-Plus on Prescription Drugs

( May 13, 2015 - Pricey cancer drugs, expensive new cures for hepatitis and made-to-order drugs have driven U.S. prescription costs to new highs for some Americans, according to a report issued Wednesday.
read article 

Letter: Cost Barrier to Medicines

(New York Times) May 12, 2015 - Re “Runaway Drug Prices” (editorial, May 5): If you are truly concerned about the problems faced by patients seeking access to needed medicines, you would do well to explore the insurance industry’s recent expansion of the use of specialty tier cost-sharing, in which patients must pay a relatively high percentage of their drug costs rather than a flat co-payment.
read article 

The Biotech Targeting Personalized Medicine

(CNBC) May 12, 2015 - The market for drugs targeting RNA is worth billions.
read article 

Teva Bids for Mylan amid Pressure on Copycat Drugmakers

(Financial Times [UK]) May 12, 2015 - If timing is everything, then Teva, the world’s biggest maker of generic drugs, has chosen a tricky moment to try to pull off the biggest pharmaceuticals deal of the year.
read article (free registration required) 

Administration Closes Insurance Loopholes on Prevention, from Contraception to Colonoscopies

(U.S. News & World Report/Associated Press) May 11, 2015 - From contraception to colonoscopies, the Obama administration Monday closed a series of insurance loopholes on coverage of preventive care.
read article 

Cured From Cancer, Almost

(New York Times/Well blog) May 11, 2015 - A leukemia specialist wrestles with using the word “cured,” and chooses to tone it down.
read article 

DiaTech Oncology Announces Partnership with INETICO

(PRWeb) May 12, 2015 - CorrectChemo® test to be offered as part of cancer management solutions.
read press release 

GenomeDx Announces Launch of Decipher GRID™ and Partnership with Sidney Kimmel Cancer Center to Accelerate Innovation in Urologic Cancer Patient Care

(GenomeDx) May 12, 2015 - GenomeDx Biosciences today announced the launch of the Decipher® Genomics Resource Information Database (Decipher GRID™), a clinical genomics data sharing program that unites patient registries from leading cancer centers with GenomeDx's full genome profiling platform.
read corporate press release 

United Healthcare Approves Coverage for Biodesix’ VeriStrat Test

(Yahoo! Finance) May 12, 2015 - Making blood-based molecular diagnostic testing accessible for patients with advanced non-small cell lung cancer (NSCLC).
read article 

NCCN Guidelines Recommend Tumor Treating Fields as a Standard Treatment Option for Recurrent Glioblastoma

(Yahoo! Finance) May 11, 2015 - Novocure, a commercial stage oncology company, announced today that Optune has been added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Central Nervous System Cancers.
read article 

FDA Grants Priority Review for Novocure’s PMA Application of Optune

(Pharmaceutical Business Review) May 12, 2015 - The US Food and Drug Administration (FDA) has accepted for filing and review as well as granted priority review status for Novocure's premarket approval (PMA) application for Optune.
read article 

Expert Predictions: Cancer Care 10 Years From Now

(ACS) May 6, 2015 - Ten American Cancer Society Research Professors share their perspectives and predictions for how cancer research will evolve over the next 10 years – and what this might mean for patients.
read article 

GSK's Curious Oncology Research Position -- A Recipe For Failure?

(Forbes) May 12, 2015 - One has to wonder about the state of mind of the research people in the GSK oncology division.
read article 

Talking Cure? For Cancer Immunotherapy, Still Many Rivers to Cross

(Xconomy) May 12, 2015 - On stage at Xconomy’s annual Seattle biotech forum last week, I asked veteran cancer researcher D. Gary Gilliland, the new president and director of Seattle’s Fred Hutchinson Cancer Research Center—which brandishes the tag line “Cures Start Here”—if now, more than a decade into the genomic era, we’re justified to talk about cures.
read article 

Pharma Reveals its ASCO Presentation Data

(Pharmafile [UK]) May 12, 2015 - AstraZeneca, Genentech and AbbVie have all revealed which cancer drugs they will show data for at The American Society of Clinical Oncology (ASCO) this year.
read article 

Baxter to Buy Leukemia Treatment Oncaspar for $900 Million

(Wall Street Journal) May 12, 2015 - Baxter International Inc. on Tuesday said it agreed to buy the Oncaspar leukemia treatment from Italy’s Sigma-Tau Finanziaria S.p.A. for $900 million in a move to capitalize on the fast-growing oncology market.
read article (paid subscription required) 

Takeda Announces First Patient Enrolled in Global Phase 3 Study of Ixazomib as Maintenance Therapy for Newly Diagnosed Multiple Myeloma

(Takeda) May 12, 2015 - TOURMALINE-MM4 study will evaluate investigational oral proteasome inhibitor ixazomib in newly diagnosed multiple myeloma patients who responded to initial therapy and have not received autologous stem cell transplant.
read article 

Significant Progress Made Towards Individualized Cancer Immunotherapy

(University of Mainz [Germany]) May 12, 2015 - Mainz-based researchers have managed to identify the relevant genetic changes or mutations associated with various types of cancer and have determined their individual blueprints.
read press release 

Disrupting Cancer Pathway Could Enhance New Immunotherapies

(University of Chicago Medicine) May 11, 2015 - Understanding how to overrule a signaling pathway that can cause treatments to fail in metastatic melanoma patients should help physicians extend the benefits of recently approved immunity-boosting drugs known as checkpoint inhibitors to more patients.
read press release 

First Cancer-promoting Oncogenes Discovered in Rare Brain Tumor of Children and Adults

(St. Jude Children’s) May 11, 2015 - Researchers have identified three genes that play a pivotal role in the brain tumor choroid plexus carcinoma (CPC), a discovery that lays the groundwork for more effective treatment of this rare, often fatal cancer.
read press release